97 related articles for article (PubMed ID: 23745955)
1. Effect of mycophenolic acid and bortezomib on purified human B cells: an in vitro study of long-term functionally stable MICA-sensitized renal recipients.
Li Zw; Wen Xf; Wang Y; Luo M; Qiu Jx
Exp Clin Transplant; 2013 Dec; 11(6):482-8. PubMed ID: 23745955
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib affects the function of human B cells: possible implications for desensitization protocols.
Heidt S; Roelen DL; Vergunst M; Doxiadis II; Claas FH; Mulder A
Clin Transpl; 2009; ():387-92. PubMed ID: 20524303
[TBL] [Abstract][Full Text] [Related]
3. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F
Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of bortezomib on HLA class I and class II antibody.
Philogene MC; Sikorski P; Montgomery RA; Leffell MS; Zachary AA
Transplantation; 2014 Sep; 98(6):660-5. PubMed ID: 24798311
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibition profoundly affects activated human B cells.
Mulder A; Heidt S; Vergunst M; Roelen DL; Claas FH
Transplantation; 2013 Jun; 95(11):1331-7. PubMed ID: 23624544
[TBL] [Abstract][Full Text] [Related]
6. Children with chronic renal failure have reduced numbers of memory B cells.
Bouts AH; Davin JC; Krediet RT; Monnens LA; Nauta J; Schröder CH; van Lier RA; Out TA
Clin Exp Immunol; 2004 Sep; 137(3):589-94. PubMed ID: 15320911
[TBL] [Abstract][Full Text] [Related]
7. Decrease of immature B cell and interleukin-10 during early-post-transplant period in renal transplant recipients under tacrolimus based immunosuppression.
Chung BH; Kim KW; Yu JH; Kim BM; Choi BS; Park CW; Kim YS; Cho ML; Yang CW
Transpl Immunol; 2014 May; 30(4):159-67. PubMed ID: 24709525
[TBL] [Abstract][Full Text] [Related]
8. Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates.
Wahrmann M; Haidinger M; Körmöczi GF; Weichhart T; Säemann MD; Geyeregger R; Kikić Z; Prikoszovich T; Drach J; Böhmig GA
Transplantation; 2010 Jun; 89(11):1385-90. PubMed ID: 20335829
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
Han M; Rogers JA; Lavingia B; Stastny P
Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of CD72 expression on CD19
Lyu M; Hao Y; Li Y; Lyu C; Liu W; Li H; Xue F; Liu X; Yang R
Br J Haematol; 2017 Jul; 178(2):308-318. PubMed ID: 28419421
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.
D'Orsogna LJ; Wright MP; Krueger RG; McKinnon EJ; Buffery SI; Witt CS; Staples N; Loh R; Cannell PK; Christiansen FT; French MA
Biol Blood Marrow Transplant; 2009 Jul; 15(7):795-803. PubMed ID: 19539210
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of catalytic proteasome subunits and resistance toward proteasome inhibition of B lymphocytes from patients with primary sjogren syndrome.
Martinez-Gamboa L; Lesemann K; Kuckelkorn U; Scheffler S; Ghannam K; Hahne M; Gaber-Elsner T; Egerer K; Naumann L; Buttgereit F; Dörner T; Kloetzel PM; Burmester GR; Faustman DL; Feist E
J Rheumatol; 2013 May; 40(5):663-73. PubMed ID: 23504381
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction.
Sharma KG; Radha R; Pao A; Amet N; Baden L; Jordan SC; Toyoda M
Transpl Immunol; 2010 Jul; 23(3):117-20. PubMed ID: 20450974
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
16. Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis.
Lin Q; Gu JR; Li TW; Zhang FC; Lin ZM; Liao ZT; Wei QJ; Cao SY; Li L
Chin Med J (Engl); 2009 Aug; 122(15):1784-9. PubMed ID: 19781326
[TBL] [Abstract][Full Text] [Related]
17. CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
Néron S; Boire G; Dussault N; Racine C; de Brum-Fernandes AJ; Côté S; Jacques A
Arch Immunol Ther Exp (Warsz); 2009; 57(6):447-58. PubMed ID: 19866343
[TBL] [Abstract][Full Text] [Related]
18. Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade).
Arpinati M; Chirumbolo G; Nicolini B; Agostinelli C; Rondelli D
Bone Marrow Transplant; 2009 Feb; 43(3):253-9. PubMed ID: 18806836
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against MICA antigens and kidney-transplant rejection.
Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
